New York, June 08, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Next-Generation Antibody Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Therapeutic Area, Technology, and Geography,” the report highlights trends prevailing in the market and factors driving its growth. The growth of the market is attributed to the rising prevalence of cancer worldwide and the increasing demand for next-generation antibody. However, the complications associated with manufacturing and approvals hamper the market growth.
The Sample Pages Showcases Content Structure and Nature of Information Included in This Research Study Which Presents A Qualitative and Quantitative Analysis: https://www.theinsightpartners.com/sample/TIPRE00006412/
| Report Coverage | Details |
| Market Size Value in | US$ 5.46 billion in 2021 |
| Market Size Value by | US$ 12.05 Billion by 2028 |
| Growth rate | CAGR of 11.9% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 181 |
| No. Tables | 58 |
| No. of Charts & Figures | 70 |
| Historical data available | Yes |
| Segments covered | Therapeutic Area, and Technology |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Next-Generation Antibody Market: Competitive Landscape and Key Developments
F. HOFFMANN-LA…
